^
    BIOMARKER:

    KMT2A rearrangement + CD19 positive

    i
    Other names: KMT2A, Lysine Methyltransferase 2A, Histone-Lysine N-Methyltransferase 2A, CXXC7, TRX1, Myeloid/Lymphoid Or Mixed-Lineage Leukemia (Trithorax Homolog, Drosophila), Lysine (K)-Specific Methyltransferase 2A, CXXC-Type Zinc Finger Protein 7, Lysine N-Methyltransferase 2A, Zinc Finger Protein HRX, Trithorax-Like Protein, HTRX1, MLL1A, MLL1, MLL, Myeloid/Lymphoid Or Mixed-Lineage Leukemia (Trithorax (Drosophila) Homolog), Myeloid/Lymphoid Or Mixed-Lineage Leukemia Protein 1, Myeloid/Lymphoid Or Mixed-Lineage Leukemia, Mixed Lineage Leukemia 1, WDSTS, ALL1, HTRX, CD19, CD19 Molecule, B-Lymphocyte Surface Antigen B4, T-Cell Surface Antigen Leu-12, Differentiation Antigen CD19, B-Lymphocyte Antigen CD19, CD19 Antigen, CVID3, B4
    Entrez ID:
    930; 4297
    Related biomarkers:
    Expression
    Mutation
    CNA
    Fusion
    Others

    Associations

    Heatmap
    News
    Twitter
    Trials
    KMT2A rearrangement + CD19 positive
    ALL
    tisagenlecleucel-T
    Sensitive: C3 – Early Trials
    KMT2A rearrangement + CD19 positive
    ALL
    CD19-targeted CAR-T immunotherapy
    Sensitive: C3 – Early Trials